Inventor · disambiguated record
David Gunn
Also filed as: GUNN DAVID · GUNN DAVID E · GUNN JR DAVID E
24 granted patents·11 pending applications·589 citations·filing 1994–2012
97Inventor score
Files withABBOTT LAB9BAYER PHARMACEUTICALS CORP6BAYER AG4INST PHARMACEUTICAL DISCOVERY4MILLER SCOTT3
Top patents by PatentIndex Score
35 records- 0194US5948793A3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter releaseABBOTT LAB·Filed 1995·Granted Sep 7, 1999·77 cites·8 claims
- 0292US6730794B2Substituted indolealkanoic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2002·Granted May 4, 2004·34 cites·38 claims
- 0391US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 0491US5914328AHeterocyclic ether compounds useful in controlling neurotransmitter releaseABBOTT LAB·Filed 1995·Granted Jun 22, 1999·67 cites·31 claims
- 0589US6426344B2Aryl and heteroaryl substituted indolealkanoic acidsINST FOR PHARM DISCOVERY INC·Filed 2001·Granted Jul 30, 2002·28 cites·24 claims
- 0688US6344476B1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 1998·Granted Feb 5, 2002·82 cites·18 claims
- 0787US7304079B2Substituted indolealkanoic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2006·Granted Dec 4, 2007·7 cites·6 claims
- 0886US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 0986US7105514B2Substituted indolealkanoic acidsINST DIBETES DISCOVERY LLC·Filed 2004·Granted Sep 12, 2006·22 cites·5 claims
- 1086US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 1185US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 1285US6214991B1Substituted indolealkanoic acidsINST PHARMACEUTICAL DISCOVERY·Filed 1999·Granted Apr 10, 2001·40 cites·50 claims
- 1384US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 1479US5472958A2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive functionABBOTT LAB·Filed 1994·Granted Dec 5, 1995·55 cites·3 claims
- 1577US8431695B2Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesO'CONNOR STEPHEN·Filed 2006·Granted Apr 30, 2013·5 cites·6 claims
- 1676US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 1776US5691351ABis-(Heteroarylmethoxyphenyl)cycloalkyl carboxylates as inhibitors of leukotriene biosynthesisABBOTT LAB·Filed 1996·Granted Nov 25, 1997·21 cites·8 claims
- 1875US7659269B2Substituted indolealkanoic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2007·Granted Feb 9, 2010·1 cites·15 claims
- 1967US8163932B2Substituted indolealkanoic acidsJONES MICHAEL LEE·Filed 2010·Granted Apr 24, 2012·1 cites·17 claims
- 2066US5756531AIminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesisABBOTT LAB·Filed 1996·Granted May 26, 1998·14 cites·9 claims
- 2160US2010160371A1Inhibition of p38 kinase activity by aryl ureasRANGES GERALD·Filed 2009·Application pending·0 cites
- 2259US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 2359US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 2458US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 2557US2010324039A1Substituted Indolealkanoic AcidsINST PHARMACEUTICAL DISCOVERY LLC·Filed 2010·Application pending·0 cites
- 2656US2012270912A1Substituted Indolealkanoic AcidsJONES MICHAEL LEE·Filed 2012·Application pending·0 cites
- 2752US5795900ASymmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesisABBOTT LAB·Filed 1996·Granted Aug 18, 1998·9 cites·16 claims
- 2852US2008269265A1Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl UreasMILLER SCOTT·Filed 2008·Application pending·0 cites
- 2952US2012270878A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2012·Application pending·0 cites
- 3046US5783586AHeteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesisABBOTT LAB·Filed 1996·Granted Jul 21, 1998·3 cites·8 claims
- 3146US2002103253A1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 2001·Application pending·0 cites
- 3240US2003207914A1Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER AG·Filed 2002·Application pending·0 cites
- 3339US5668150ANon-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesisABBOTT LAB·Filed 1996·Granted Sep 16, 1997·3 cites·8 claims
- 3438US2002065296A1Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 3537US5843968ASymmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesisABBOTT LAB·Filed 1997·Granted Dec 1, 1998·2 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when David Gunn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →